References
- Dolgin E. Technology: barriers to misuse. Nature. 2015 Jun 25;522:S60–S61.
- Mastropietro DJ, Omidian H. Abuse-deterrent formulations: part 1 – development of a formulation-based classification system. Expert Opin Drug Metab Toxicol. 2015;11:193–204.
- Mastropietro DJ, Omidian H. Abuse-deterrent formulations: part 2: commercial products and proprietary technologies. Expert Opin Pharmacother. 2015;16:305–323.
- Mastropietro D, Muppalaneni S, Kariman A, et al. Shear-thinning rheology of the abuse-deterrent dosage form extracts. J Dev Drugs. 2013;2:1–3.
- U.S. Food and Drug Administration. FDA statement: original opana ER relisting determination. 2013 [cited 2015 Aug 4]. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm351357.htm
- U.S. Food and Drug Administration. Cancelled: July 7–8, 2015: joint meeting of the drug safety and risk management advisory committee and the anesthetic and analgesic drug products advisory committee meeting announcement. 2015 [cited 2015 Aug 6]. Available from: http://www.fda.gov/advisorycommittees/calendar/ucm448718.htm
- M2 Polymer Technologies Inc. Waste Lock superabsorbent polymer: determination of absorbency ratio. [ cited 2015 Aug 6]. Available from: http://www.m2polymer.com/pdf/Absorbency%20Ratio%20Calculation.pdf
- ETI Emerging Technologies Inc. Technical data: liquiblock 2G-40. [ cited 2015 Aug 6]. Available from: http://www.thesuperabsorbentsource.com/uploads/2G-40.pdf
- Tramfloc Inc. Technical information bulletin: tramfloc 1002 superabsorbent polymer. [ cited 2015 Aug 6]; Available from: http://www.tramfloc.com/Zpds1002.pdf
- Castle International Resources. Company profile: hydrosource CLP. [ cited 2015 Aug 6]. Available from: http://www.hydrosource.com/
- Quadir A, Kolter K. A comparative study of current superdisintegrants. Pharmaceutical Technology. 2006 [cited 2015 Aug 6]. Available from: http://www.pharmtech.com/pharmtech/Excipients/A-Comparative-Study-of-Current-Superdisintegrants/ArticleStandard/Article/detail/378399
- BASF the Chemical Company. Tehnical information: insoluble Kollidon grades. 2011 [cited 2015 Aug 6]. Available from: http://www.pharma-ingredients.basf.com/Statements/Technical%20Informations/EN/Pharma%20Solutions/03_030753e_Insoluble%20Kollidon%20grades.pdf
- Raju MP, Raju KM. Design and synthesis of superabsorbent polymers. J Appl Polym Sci. 2001 Jun 28;80:2635–2639.
- Gaur S, Levy S, Wecker J, et al., inventors; Methods and devices for deploying and releasing a temporary implant within the body. U.S. Patent Application No. 2013/0267984. 2013.
- Passik SD. Tamper-resistant opioid formulations in the treatment of acute pain. Adv Ther. 2014 Mar;31:264–275. Epub 2014 Feb 14.
- Rosenberg J, Woehrle G, Kessler TY, et al., inventors; Formulations of nonopioid and confined opioid analgesics. U.S. Patent Application No. 2013/0344143. 2013.
- Gower B, Castaneda CH, Park JH, et al., inventors; Extended release, abuse deterrent pharmaceutical compositions. U.S. Patent Application No. 2014/0017310. 2014.
- Kumar V, Dixon D, Tewari D, et al., inventors; Compositions for deterring abuse of opioid containing dosage forms. US8637540. 2014
- Betancourt AO, Gosselin PM, Vinson RK. New immediate release formulation for deterring abuse of methadone. Pharm Dev Technol. 2013 Mar–Apr;18:535–543.
- Cone EJ, Giordano J, Weingarten B. An iterative model for in vitro laboratory assessment of tamper deterrent formulations. Drug Alcohol Depend. 2013 Jan 16;131:100–105.
- McLean S, Bruno R, Brandon S, et al. Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets. Harm Reduct J. 2009;6:37.
- Vachon M, Rudnic EM, inventors; Technology for preventing abuse of solid dosage forms. U.S. Patent Application No. 2012/0321716. 2012.
- Raju KM, Raju MP. Synthesis and swelling properties of superabsorbent copolymers. Adv Polymer Technol. 2001;20:146–154.
- Omidian H, Mastropietro DJ, Muppalaneni S, inventors; Deterring abuse of pharmaceutical products and alcohol. International patent application No. WO2015035423. 2014.